跳至主要内容
临床试验/NCT06184594
NCT06184594Enrolling By Invitation不适用

Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年1月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
400
试验地点
1
主要终点
Colorectal Cancer (CRC) Screening completion

研究概览

简要总结

The purpose of this research study is to evaluate the efficacy of a digital navigation tool, called the eNav to improve colorectal cancer screening uptake among patients treated at federally qualified health centers (FQHC)s. The digital navigation tool includes a website and text messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).

详细描述

This is a multi-site randomized clinical trial to evaluate the efficacy of the eNav Toolkit. A total of 400 participants will be from four FQHC clinics within the Institute for Family Health FQHC network. Participants will be randomly assigned to one of two groups:

  1. eNav group (N=200) or
  2. usual care group (N=200)

Participants will consent and complete a baseline questionnaire (demographics, medical information) 1-4 weeks before their primary care appointment.

Those in the intervention group will receive a link to the eNav website. The digital navigation tool includes a website and text-messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).

The control group will receive standard clinical care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient treated at the Institute for Family Health (IFH)
  • Patient 45 to 75 years old
  • English or Spanish speaking
  • Able to provide consent within the study time frame (within a month of the primary care appointment
  • Patients have access to a computer, tablet or mobile device to access the eNav Toolkit OR willing to use a clinic provided device, in person at either IFH OR Mount Sinai
  • Patient scheduled for a primary care appointment at IFH
  • Patients are due for colorectal cancer screening (as determined by the health maintenance alert in the medical chart)

排除标准

  • Unable to provide informed consent

研究组 & 干预措施

eNav intervention

Experimental

Subjects assigned to this arm will receive a link to the eNav website.

干预措施: eNav (Other)

Usual Care Group

Placebo Comparator

Subjects assigned to this arm will not receive the link to the website and will receive standard clinical care.

干预措施: Standard of Care (Other)

结局指标

主要结局

Colorectal Cancer (CRC) Screening completion

时间窗: End of study, at 6 months

CRC, Yes/No Medical chart review will determine whether the CRC screening was complete. If a patient does not have a CRC screening result recorded in their medical record, the research team will call the patient to inquire whether they have completed the CRC screening.

次要结局

  • Number of participants who complete screening tests with adequate quality(End of study, at 6 months)
  • Number of participants who complete the screening test with inadequate preparation(End of study, at 6 months)
  • Adherence to follow up recommendations(End of study, at 6 months)
  • The Colorectal Cancer Screening Beliefs Instrument Score(Approximately 3-4 weeks after primary care appointment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Miller

Assistant Professor

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验

Evaluating the Efficacy of the eNav Toolkit to... | 临床试验